Wednesday, January 14, 2015

Resist This...

Antibiotic resistance continues to be a growing global medical concern.  In fact, two recent incidents highlight the importance of this issue: first, a recent report from the UK government predicts that antibiotic resistance could result in 10 million deaths and trillions in economic costs by the year 2050; and second, the CDC director (who is an Obama tool, by the way) claims it will be the next "pandemic" for humanity.  So with that as a backdrop, the development of a new drug, teixobactin, has medical researchers excited.  From an account at Atlantic:
Teixobactin may encounter bacterial resistance further down the road, Lewis admits, though he predicts it would be at a slower pace than most antibiotics. While widespread resistance to new drugs typically takes anywhere from weeks to years, Lewis anticipates that resistance to teixobacitn may take decades to develop, citing vancomycin, a drug often used to treat MRSA infections, and considered a drug of last resort—one typically saved unless there are no other options. Developed in England in the 1960s, vancomycin, which also targets a bacterial cell-wall polymer rather than a protein, only began to encounter resistance in the 1990s. “So that gives us an idea of how long it will take for resistance to develop to teixobactin,” he says. “It should take more than 30 years.”
Click here to read the rest of this highly informative article.